DB
PYXS icon

Dmitry Balyasny’s Pyxis Oncology PYXS Stock Holding History

Dmitry Balyasny’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-743
Closed -$1.08K – 3409
2026
Q1 		$1.08K Sell
743
-7,484
-91% -$11.3K ﹤0.01% 2805
2025
Q4 		$9.46K Buy
+8,227
New +$29K ﹤0.01% 3026
2024
Q4 		– Sell
-224,957
Closed -$826K – 3169
2024
Q3 		$826K Sell
224,957
-2,337,985
-91% -$8.18M ﹤0.01% 2043
2024
Q2 		$8.48M Sell
2,562,942
-31,382
-1% -$132K 0.01% 957
2024
Q1 		$11.1M Buy
+2,594,324
New +$10.9M 0.02% 876

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dmitry Balyasny's PYXS Position: Q2 2026 in Review

Dmitry Balyasny sold out of Pyxis Oncology (PYXS) in Q2 2026, closing a stake of 743 shares — an estimated $1.08K sold.

Dmitry Balyasny first reported a position in PYXS in Q1 2024 and held it in 5 quarters. The position peaked at $11.1M in Q1 2024. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Dmitry Balyasny reported no remaining Pyxis Oncology position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 743 Pyxis Oncology shares in Q2 2026, an estimated $1.08K.
  • Dmitry Balyasny first reported a position in Pyxis Oncology in Q1 2024 and held it in 5 quarters.
  • Dmitry Balyasny's Pyxis Oncology position peaked at $11.1M in Q1 2024.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.